DDB Health


Scemblix – “The Giant” Campaign

Scemblix was launching with a unique combination of benefits to help patients with later-line chronic myeloid leukemia (CML). But the current market was content with its existing options. To break through, Scemblix needed a campaign that highlighted its unprecedented benefits.

So DDB Health and Novartis flipped the script on a popular saying. Scemblix delivers the power you’d expect of the “bull in a china shop,” but not the collateral damage. This unexpected combination of power, carefully provided, is what patients with later-line CML really need.


You May Also Like

Rob Califf and the Future of Accelerated Approval

If the regulatory, policy, and political temper tantrums over the FDA’s approval of Exondys ...

Measuring the Impact of Telehealth Marketing

In a recent “State of the Point of Care Marketing Industry 2022” report, a ...

What New Skills Are Required of Creatives Today?

The canvas that marketers have to work on has expanded—and continues to expand—as new ...